Transplantation Proceedings
Volume 41, Issue 1 , Pages 5-10 , January 2009

THE RUBY ANNIVERSARY: Forty Years of Publication of Transplantation Proceedings—The First Decade: The Flowering of Immunology and Immunogenetics

  • B.D. Kahan

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr. Barry D. Kahan, University of Texas Medical School at Houston, Department of Surgery, Division of Immunology and Organ Transplantation, 6431 Fannin, Suite 6.240, Houston, TX 77030

References 

  1. Dausset J, Hamburger J, Mathe G, eds: Advances in transplantation. Copenhagen: Munksgaard
  2. Morgan D: Fire and blood. Westport, CT: Praeger
  3. Medawar P. The future of transplantation biology and medicine. Transplant Proc. 1969;1:666
  4. Bach FH, Albertini RJ, Amos DB, et al. Mixed leukocyte culture studies in families with known HL-A genotypes. Transplant Proc. 1969;1:339
  5. In:  Curtoni ES,  Mattsuz P,  Tosi RM editor. Histocompatibility testing. Baltimore: Williams and Wilkins; 1967;
  6. Batchelor JR, Joysey VC, Crome PE. Further studies on influence of HL-A incompatibility on cadaveric renal transplantation. Transplant Proc. 1971;3:133
  7. Westbroek DL, Rothengatter C, Vriesendorp HM, et al. Histocompatibility and allograft rejection in canine small bowel transplants (Evidence for the existence of a major histocompatibility locus in the dog). Transplant Proc. 1971;3:157
  8. Palm J. Classification of inbred rat strains for Ag-B histocompatibility antigens. Transplant Proc. 1971;3:169
  9. Barker CF, Billingham RE. Histocompatibility requirements of heart and skin grafts in rats. Transplant Proc. 1971;3:172
  10. De Weck AL, Polak L, Sato W, et al. Determination of histocompatibility antigens by leukocyte typing in outbred guinea pigs and effect of matching on skin graft survival. Transplant Proc. 1971;3:192
  11. Snell GD, Cherry M, Démant P. Evidence that H-2 private specificities can be arranged in two mutually exclusive systems possibly homologous with two subsystems of HL-A. Transplant Proc. 1971;3:183
  12. Cantrell JL, Hildemann WH. Characteristics of histocompatibility barriers in congenic mice. Transplant Proc. 1973;5:271
  13. Balner H, van Vreeswijk W, Dersjant H, et al. Leukocyte antigens of chimpanzees (ChL-A). Transplant Proc. 1972;4:42
  14. Balner H, Dersjant H, van Vreeswijk W, et al. Tissue typing of rhesus monkeys: application in transplantation research. Transplant Proc. 1972;4:3
  15. Barnes AD, Hawker RJ. Leukocyte antigens in baboons: a preliminary to tissue typing for organ grafting. Transplant Proc. 1972;4:37
  16. Wiener AS, Moor-Jankowski J, Socha WW. Principles of blood grouping in apes and monkeys: human, simian, and cross-immune types. Transplant Proc. 1972;4:101
  17. Strober S, Appella E, Law LW. Characterization of the immunogenic and serological activity of soluble H-2 transplantation antigens in the mouse. Transplant Proc. 1971;3:246
  18. Halle-Pannenko O, Martyré MC, Jolles P. Conditioning of allogeneic mice with crude and purified H-2 extracts, alone and combined with cyclophosphamide, for skin graft prolongation. Transplant Proc. 1971;3:257
  19. Brent L, Hansen JA, Kilshaw PJ. Unresponsiveness to skin allografts induced by tissue extracts and antilymphocytic serum. Transplant Proc. 1971;3:684
  20. Sanderson AR, Cresswell P, Welsh KI. Implication of carbohydrate in the immunochemical determinant area of HL-A substances. Transplant Proc. 1971;3:220
  21. Kahan BD, Reisfeld RA, Pellegrino MA, et al. Water-soluble human transplantation antigen. Proc Natl Acad. Sci (Wash). 1968;61:897
  22. Eijsvoogel VP, de Groot-Kooy L, Huismans L, et al. Mixed lymphocyte culture and HL-A. Transplant Proc. 1972;4:199
  23. Sasportes M, Lebrun A, Rapaport FT, et al. Studies of skin allograft survival and mixed lymphocyte culture reaction in Hl-A-genotyped families. Transplant Proc. 1972;4:209
  24. Cochrum KC, Perkins HA, Payne RO, et al. The correlation of MLC with graft survival. Transplant Proc. 1973;5:391
  25. Hattler BG, Miller J. Changes in human mixed lymphocyte culture reactivity as an indicator of kidney rejection. Transplant Proc. 1972;4:655
  26. van Rood JJ, Koch CT, van Hooff JP, et al. Graft survival in unrelated donor-recipient pairs matched for MLC and HL-A. Transplant Proc. 1973;5:409
  27. Revillard JP, Robert M, Betuel H, et al. Inhibition of the mixed lymphocyte reaction by antibodies. Transplant Proc. 1972;4:173
  28. Hattler BG, Miller J. Blocking antibody in the sera and on the kidneys of successful human transplants. Transplant Proc. 1973;5:655
  29. Hauptfeld V, Klein D, Klein J. Serologic detection of antigens controlled by the Ir region of the H-2 complex in the mouse. Transplant Proc. 1973;5:1811
  30. Bach MA, Bach JF. Early depression of mixed lymphocyte reaction by adult thymectomy. Transplant Proc. 1972;4:165
  31. Sondel PM, Sheehy MJ, Benike C, et al. Specific detection of HLA-D antigens using primed LD typing (PLT). Transplant Proc. 1976;8:449
  32. DeWolf WC, Carroll PG, Yunis EJ. Genetic studies of the HLA-D region by the primed lymphocyte test. Transplant Proc. 1978;10:775
  33. Suciu-Foca N, Susinno E, McKiernan P, et al. DRw determinants on human T cells primed against allogeneic lymphocytes. Transplant Proc. 1978;10:845
  34. Stastny P. Joint report of the first workshop of the LD typing study group. Transplant Proc. 1977;9(1 suppl 1):13
  35. Singal DP, Naipaul N, Hidalgo R. Serotyping for B-lymphocyte alloantigens. Transplant Proc. 1977;9(1 suppl 1):141
  36. Thorsby E, Albrechtsen D, Hirschberg H, et al. MLC-activating HLA-D determinants: identification, tissue distribution, and significance. Transplant Proc. 1977;9:393
  37. van Rood JJ, van Leeuwen A, Persijn GG, et al. Role of the HLA system in transplantation (HLA compatibility in clinical transplantation). Transplant Proc. 1977;9:459
  38. Solheim BG, Flatmark A, Enger E, et al. Influence of HLA-A, -B, -C, and -D matching on the outcome of clinical kidney transplantation. Transplant Proc. 1977;9:475
  39. Salvatierra O, Perkins HA, Cochrum KC, et al. HLA typing and primary cadaver graft survival. Transplant Proc. 1977;9:495
  40. Dausset J, Contu L, Legrand L, et al. The role of HLA-DR antigens in transplantation—survival of skin allografts in HLA-haploidentical donor-recipient combinations. Transplant Proc. 1978;10:995
  41. Suthanthiran M, Gailiunas P, Fagan G, et al. Detection of anti-donor “Ia” antibodies: a strong correlate of rejection. Transplant Proc. 1978;10:605
  42. Park MS, Terasaki PI, Bernoco D, et al. Evidence for a second B-cell locus separate from the DR locus. Transplant Proc. 1978;10:823
  43. Fuller TC, Einarson M, Pinto C, et al. Genetic evidence that HLA-DR (Ia) specificities include multiple HLA-D determinants on a single haplotype. Transplant Proc. 1978;10:781
  44. Häyry P, Anderson LC. T cells in mixed-lymphocyte-culture-induced cytolysis (MLC-CML). Transplant Proc. 1973;5:1697
  45. Bach FH, Zier KS, Sondel PM. The nature of cells responding in mixed leukocyte cultures and cell-mediated lympholysis. Transplant Proc. 1973;5:1717
  46. Kissmeyer-Nielsen F, Olsen S, Petersen VP, et al. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet. 1944;2(7465):772
  47. Hume DM, Lee HM, Williams GM. Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg. 1966;164:352
  48. Cross DE, Whittier FC, Weaver P, et al. A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants. Transplant Proc. 1977;9:1803
  49. Carpenter CB, Morris PJ. The detection and measurement of pretransplant sensitization. Transplant Proc. 1978;10:509
  50. Stastny P. Endothelial monocyte antigens in man. Transplant Proc. 1978;10:875
  51. Cheng TC. Immunity in mollusca with special reference to reactions to transplants. Transplant Proc. 1970;2:226
  52. Cooper EL. Transplantation immunity in helminthes and annelids. Transplant Proc. 1970;2:216
  53. Goldstein L. Nucleo-cytoplasmic incompatibilities in free-living amoebae. Transplant Proc. 1970;2:191
  54. Hink WF. Immunity in insects. Transplant Proc. 1970;2:233
  55. Humphreys TD. Specificity of aggregation in Porifera. Transplant Proc. 1970;2:194
  56. Tartar V. Transplantation in protozoa. Transplant Proc. 1970;2:183
  57. Horton JD. Phylogenetic status of immune system in Xenopus. Transplant Proc. 1970;2:282
  58. Kallman KD. Genetics of tissue transplantation in Teleostei. Transplant Proc. 1970;2:263
  59. Cohen N. Tissue transplantation immunity and immunologic memory in Urodela and Apoda. Transplant Proc. 1970;2:275
  60. Campbell RD, Bibb C. Transplantation in coelenterates. Transplant Proc. 1970;2:202
  61. Hildemann WH. Transplantation immunity in fishes: Agnatha, Chondrichthyes and Osteichthyes. Transplant Proc. 1970;2:253
  62. Freeman G. Transplantation specificity in echinoderms and lower chordates. Transplant Proc. 1970;2:236
  63. Calne RY. Organ transplantation between widely disparate species. Transplant Proc. 1970;2:550
  64. Balner H, van Leeuwen A, van Vreeswijk W, et al. Leukocytes antigens of chimpanzees and their relation to human HL-A antigens. Transplant Proc. 1970;2:454
  65. Metzgar RS, Seigler HF. Tissue antigens of man and chimpanzees; their role in xenografting. Transplant Proc. 1970;2:463
  66. Giles GR, Boehmig HJ, Amemiya H, et al. Clinical heterotransplantation of the liver. Transplant Proc. 1970;2:506
  67. Douglas JD. Suitability and availability of chimpanzees as organ donors for man. Transplant Proc. 1970;2:539
  68. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science. 1970;169:1042
  69. Zinkernagel RM. Role of the H-2 gene complex in cell-mediated immunity to infectious disease. Transplant Proc. 1977;9:1835
  70. Gowans JL. 2: Cellular mediators of allograft immunity. Transplant Proc. 1977;9:685
  71. Feldmann M. Role of T-cell antigen-specific factor in T-B cooperation. Transplant Proc. 1973;5:111
  72. Hämmerling GJ, McDevitt HO. Frequency and characteristics of antigen binding cells in genetic high and low responder mice. Transplant Proc. 1973;5:179
  73. Barker CF, Billingham RE. Extension of skin homograft survival by prevention of graft-host skin contact. Transplant Proc. 1973;5:153
  74. Stuart FP, Bastien E, Holter A, et al. Role of passenger leukocytes in the rejection of renal allografts. Transplant Proc. 1971;3:461
  75. Steinmuller D, Hart EA. Passenger leukocytes and induction of allograft immunity. Transplant Proc. 1971;3:673
  76. Wood ML, Monaco AP, Gozzo JJ, et al. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc. 1971;3:676
  77. Floersheim GL, Brune K. Tolerance to skin allografts by immunosuppressive “pulse” of methylhydrazine derivatives and antilymphocyte serum. Transplant Proc. 1971;3:688
  78. Brent L, Hansen JA, Kilshaw PJ. Unresponsiveness to skin allografts induced by tissue extracts and antilymphocytic serum. Transplant Proc. 1971;3:684
  79. Monaco AP, Campion JP, Kapnick SJ. Antilymphocyte globulins (Clinical use of antilymphocyte globulin). Transplant Proc. 1977;9:1007
  80. Gorer PA, Boyse EA: Problems of grafting. Oxford: Blackwell Scientific
  81. Winn HJ. Humoral antibody in allograft reactions. Transplant Proc. 1970;2:83
  82. Porter KA. The effects of antibodies on human renal allografts. Transplant Proc. 1976;8:189
  83. Carpenter CB, Soulillou JP, D'Apice AJ, et al. The role of antibodies in the rejection and enhancement of rat organ allografts: non-Ag-B (Ia) antigens. Transplant Proc. 1976;8:199
  84. Milgrom F. Some serologic aspects of transplantation. Transplant Proc. 1976;8:181
  85. Kaliss N. Dynamics of immunologic enhancement. Transplant Proc. 1969;2:59
  86. Mullen Y, Hildemann WH. Kidney transplantation genetics and enhancement in rats. Transplant Proc. 1971;3:669
  87. Davis W. Enhancement of heart allograft survival across H-2 complex. Transplant Proc. 1977;9:937
  88. Fuller TC, Winn HJ. Immunochemical and biologic characterization of alloantibody active in immunologic enhancement. Transplant Proc. 1973;5:585
  89. Carpenter CB, Soulillou JP, D'Apice AJ, et al. The role of antibodies in the rejection and enhancement of rat organ allografts: non-Ag-B (Ia) antigens. Transplant Proc. 1976;8:199
  90. Batchelor JR, Joysey VC, Crome PE. Further studies on influence of HL-A incompatibility on cadaveric renal transplantation. Transplant Proc. 1971;3:133
  91. Elion GB. Pharmacologic and physical agents (Immunosuppressive agents). Transplant Proc. 1977;9:975
  92. Fitch FW, Weiss A, McKearn TJ, et al. Graft enhancement and antiidiotypic antibody (Lymphocytes from long-term rat renal allograft recipients have normal responsiveness in vitro). Transplant Proc. 1978;10:367
  93. Chanana AD, Cronkite EP, Joel DD, et al. Prolonged renal allograft survival: extracorporeal irradiation of blood. Transplant Proc. 1971;3:838
  94. Weeke E, Sorensen SF. Extracorporeal irradiation of the blood: lymphocyte transformation tests and clinical results after renal transplantation. Transplant Proc. 1971;3:387
  95. Starzl TE, Putnam CW, Halgrimson CG, et al. Renal transplantation under cyclophosphamide. Transplant Proc. 1972;4:461
  96. Slavin S, Strober S, Fuks Z, et al. Use of total lymphoid irradiation in tissue transplantation in mice. Transplant Proc. 1977;9:1001
  97. Sollinger HW, Burkholder PM, Kuperman OJ, et al. Xenotransplantation (Prolonged survival of xenografts after organ culture). Transplant Proc. 1977;9:359
  98. Jeannet M, Werner C, Ramirez E, et al. Anti-HLA, anti-human “Ia-like” and MLC blocking activity of human placental IgG. Transplant Proc. 1977;9:1417
  99. Riggio RR, Saal SD, Stenzel KH, et al. Retroplacental serum factors and passive enhancement. Transplant Proc. 1976;8:281
  100. Steinmuller D. Cross-species transplantation in embryonic and neonatal animals. Transplant Proc. 1970;2:438
  101. Billington WD, Jenkinson EJ, Searle RF, et al. Alloantigen expression during early embryogenesis and placental ontogeny in the mouse: immunoperoxidase and mixed hemadsorption studies. Transplant Proc. 1977;9:1371
  102. Faulk WP, Sanderson AR, Temple A. Distribution of MHC antigens in human placental chorionic villi. Transplant Proc. 1977;9:1379
  103. Pellegrino MA, Pellegrino A, Kahan BD. Solubilization of fetal HL-A antigens. Transplantation. 1970;10:425
  104. Beer AE, Billingham RE, Hoerr RA. Elicitation and expression of transplantation immunity in the uterus. Transplant Proc. 1971;3:609
  105. Beer AE, Head JR, Smith WG. Some immunoregulatory aspects of pregnancy in rats. Transplant Proc. 1976;8:267
  106. Najarian JS, Merkel FK, Moore GE, et al. Clinical use of anti lymphoblast serum. Transplant Proc. 1969;1:460
  107. Starzl TE, Brettschneider L, Penn I, et al. A Trial with heterologous antilymphocyte globulin in man. Transplant Proc. 1969;1:448
  108. Lillehei RC, Idezuki Y, Kelly WD, et al. Transplantation of the intestine and pancreas. Transplant Proc. 1969;1:230
  109. Starzl TE, Brettschneider L, Penn I, et al. Orthotopic liver transplantation in man. Transplant Proc. 1969;1:216
  110. Hume DM, Leo J, Rolley RT, et al. Some immunological and surgical aspects of kidney transplantation in man. Transplant Proc. 1969;1:171
  111. Lawrence HS. The immunology of transplantation. Transplant Proc. 1969;1:645
  112. Woodruff MF. Antilymphocytic serum and its mode of action. Transplant Proc. 1971;3:34
  113. Traeger J, Touraine JL, Fries D, et al. Evaluation of intravenous route for administration of antilymphocyte globulins in humans. Transplant Proc. 1971;3:749
  114. Collins GM, Bravo-Shugarman M, Novom S, et al. Kidney preservation for transplantation (1. Twelve-hour storage in rabbits). Transplant Proc. 1969;1:801
  115. Abbott WM, Sell KW. Organ preservation in transplantation. Transplant Proc. 1969;1:781
  116. Rapaport FT, Markowitz AS, McCluskey RT, et al. Induction of renal disease with antisera to group A streptococcal membranes. Transplant Proc. 1969;1:981
  117. Kaplan MH. Cross-reaction of group A streptococci and heart tissue: varying serologic specificity of cross-reactive antisera and relation to carrier-hapten specificity. Transplant Proc. 1969;1:976
  118. Zabriskie JB. The relationship of streptococcal cross-reactive antigens to rheumatic fever. Transplant Proc. 1969;1:968
  119. Merrill JP. Glomerulonephritis in renal transplants. Transplant Proc. 1969;1:994
  120. Shumway NE, Stinton EB, Dong E. Cardiac homotransplantation in man. Transplant Proc. 1969;1:739
  121. Lower RR. Rejection of the transplanted heart. Transplant Proc. 1969;1:733
  122. Hardy JD, Chavez CM. The first heart transplant in man: historical reexamination of the 1964 case in the light of current clinical experience. Transplant Proc. 1969;1:717
  123. Cooley DA, Norra JJ, Trentin JJ, et al. Clinical experience in transplantation of the human heart: report of ten cases. Transplant Proc. 1969;1:703
  124. Cooley DA. The first implantation of an artificial heart: reflections and observations. Transplant Proc. 1973;5:1135
  125. Turina M, Bosio R, Senning A. Evaluation of a fluid-controlled artificial heart. Transplant Proc. 1976;8:53
  126. Bevilacqua S. The nuclear artificial heart. Transplant Proc. 1976;8:63
  127. Austen WG, Buckley MJ, Mundth ED, et al. Counterpulsation with an intraaortic balloon: present-day use in the patient with left ventricular ischemia. Transplant Proc. 1976;8:75
  128. Deutsch M, Fasching W, Horcher E, et al. Experience with two different ventriculoaortic bypass pumps: hemodynamic and long-term evaluation. Transplant Proc. 1976;8:91
  129. Bregman D, Parodi EN, Edie RN, et al. Unidirectional intraaortic balloon pumping (IABP) and open-heart surgery. Transplant Proc. 1976;8:79
  130. Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253
  131. Marquet RL, Heystek GA, Tinbergen WJ. Specific inhibition of organ allograft rejection by donor blood. Transplant Proc. 1971;3:708
  132. Jeekel J, van Dongen J, Majoor G, et al. Enhancement of rat renal allograft with antibodies directed against erythrocyte-associated antigens (EAA). Transplant Proc. 1977;9:969
  133. Kahan BD. Donor-specific transfusions—a balanced view. In:  Morris P,  Tilney N editor. Progress in transplantation. Vol. 1:London: Churchill-Livingston; 1984;p. 115
  134. Kjellstrand CM. Side effects of steroids and their treatment. Transplant Proc. 1975;7:123
  135. Humphries AL, Stoddard LD. Does preservation injury predipose to rejection injury?. Transplant Proc. 1976;8(2 suppl 1):209
  136. Häyry P, Pasternack A, Virolainen M. Cell proliferation within graft and in blood during renal allograft rejection. Transplant Proc. 1972;4:195
  137. Häyry P, Roberts PJ. Allograft-infiltrating killer cells. Transplant Proc. 1977;9:691
  138. Opelz G, Mickey MR, Terasaki PI. Influence of race on kidney transplant survival. Transplant Proc. 1977;9:137
  139. Penn I, Hammond W, Brettschneider L, et al. Malignant lymphomas in transplantation patients. Transplant Proc. 1969;106:1
  140. Penn I. Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977;9:1121
  141. Sheil AG. Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc. 1977;9:1133

PII: S0041-1345(08)01643-6

doi: 10.1016/j.transproceed.2008.12.001

Transplantation Proceedings
Volume 41, Issue 1 , Pages 5-10 , January 2009

Article Tools